The study released today by the European Commission on products from new GM techniques like CRISPR-Cas shows that the institution has been lending its ears almost entirely to the biotech industry.

(.....)

Nina Holland, researcher at Corporate Europe Observatory said: “DG SANTE has clearly listened more to the biotech lobby than to anyone else. Its study on new GMOs is yet another example of the corporate capture of EU decision-making. This started right from the Commission's extremely biased stakeholder consultation that fed into this study, favouring industry voices.”